Pharma Commercial Excellence Summit

Apri 2-3, 2025 | The Westin Madrid Cuzco

Join us at the 2nd Annual Pharma Commercial Excellence Summit to explore how DTC Clinical AI is transforming patient engagement and accelerating diagnosis. Don’t miss our interactive panel discussion on the role of AI in Launch Excellence, where we’ll unpack actionable insights for patient and HCP communication alongside pharma’s leading voices.

Let's connect in Madrid

Want to dive deeper? Book a 1:1 meeting with us to discuss how Ada can help you:

  • Improve patient identification and accelerate diagnosis
  • Engage patients at critical decision-making moments
  • Optimize your digital health and omnichannel strategies for more impactful launches

Interactive Panel: "The role of AI in Launch Excellence - Actionable Insights for Patient and HCP Communication "

 April 2nd, 2025
17:35 CET  

Ada Health will be leading an interactive discussion at the Pharma Commercial Excellence Summit on how AI is reshaping the path to launch success.

Together with senior leaders from top pharmaceutical companies, we’ll explore how AI is helping teams unlock smarter, more personalized communication with patients and HCPs — and what it takes to make that a reality.

This open session is designed for conversation, not just observation. Join us as we tackle the real-world opportunities and challenges in applying AI to omnichannel strategy, regulatory compliance, and data-driven engagement. Let’s talk about what’s working — and what’s next.

Speakers:

Randal Whitmore

Commercial Product Lead,
Ada Health

Andy Parker

EMEA Ecommerce Sales & Commercial Director,
Bayer

Stephane Brocker

VP, Head of Strategic Business Excellence – Global, Ipsen

Mark Petersen

Global Head of Omnichannel Execution Excellence, Boehringer Ingelheim
Eva Tiniakou
Associate Director Commercial Capabilities Lead Europe, Teva Pharmaceuticals
Yariv Hefez
Senior Vice President Head Global Business Franchise Oncology, Merck Group
Please enable JavaScript in your browser to complete this form.

I hereby agree to the processing of my personal data for the purpose of contacting me in accordance with Art. 6 para. 1 lit. a General Data Protection Regulation (GDPR).

Opt-In